NEW YORK, Jan 25 — Pfizer Inc and BioNTech SE said today they started a clinical trial to test a new version of their vaccine specifically designed to target the Covid-19 Omicron variant, which has eluded some of the protection provided by the original two-dose vaccine regimen.
They are also testing a fourth dose of the current vaccine against a fourth dose of the Omicron-based vaccine in people who received their third dose of the Pfizer/BioNTech vaccine three to six months earlier. “While current research and real-world data show that boosters continue to provide a high level of protection against severe disease and hospitalization with Omicron, we recognise the need to be prepared in the event this protection wanes over time and to potentially help address Omicron and new variants in the future,” Pfizer’s head of vaccine research and development, Kathrin Jansen, said in a statement.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pfizer urged to sell more Covid pills to developing countriesPfizer's Paxlovid is expected to be a key tool in treating Covid-19.
Source: malaysiakini - 🏆 20. / 51 Read more »
Advocacy group urges Pfizer to sell more Covid pills to developing countries | Malay MailNEW YORK, Jan 24 — An influential consumer advocacy group is pressing Pfizer Inc to supply more of its new Covid-19 pill Paxlovid to developing countries this year, concerned that access to the treatment will mirror inequalities in vaccines. Public Citizen sent a letter to Pfizer Chief Executive...
Source: malaymail - 🏆 1. / 86 Read more »
EU regulator set to rule on Pfizer Covid pill by end-Jan, ahead of Merck, says source | Malay MailBRUSSELS, Jan 24 — The European Union’s drug regulator is set to decide whether to approve Pfizer’s Covid-19 pill at the end of this month, before doing a final review of Merck’s similar but less effective drug in February, a source with knowledge of the matter said. Late last year, the...
Source: malaymail - 🏆 1. / 86 Read more »
Australia Covid-19 deaths mount as return to school threatens new Omicron peak | Malay MailSYDNEY, Jan 24 — Australia recorded another surge of Covid-19 deaths on Monday as an outbreak of the highly contagious Omicron variant peaked, and authorities warned numbers could rise further when schools return from end-of-year holidays next week. The world No. 13 economy is trying to strike a...
Source: malaymail - 🏆 1. / 86 Read more »
South Korea’s daily Covid-19 count tops 8,000 for first time amid Omicron spread | Malay MailSEOUL, Jan 25 — South Korea’s daily count of new coronavirus cases topped 8,000 for the first time today, as the highly contagious Omicron variant spreads rapidly despite the recent extension of strict social-distancing rules to slow infection. The Korea Disease Control and Prevention Agency...
Source: malaymail - 🏆 1. / 86 Read more »